Axcan Pharma AXCA
-
Axcan to Be Acquired
Axcan Pharma AXCA announced Thursday that it has agreed to be acquired by private-equity firm TPG Capital for $1.3 billion in cash, or $23 …
-
Axcan to Be Acquired
Axcan Pharma AXP announced Thursday that it has agreed to be acquired by private-equity firm TPG Capital for $1.3 billion in cash, or …
-
Great Third Quater for Axcan
Axcan Pharma AXCA reported third-quarter results Aug. 9 that exceeded our expectations, and we plan to moderately raise our fair value estimate …
-
Axcan's Excellent 2Q
Axcan Pharma AXCA reported second-quarter results May 10 that indicate the firm will meet our high expectations for the full year 2007, so we …
-
Axcan Raises Forecast
Axcan Pharma AXCA reported excellent first-quarter results Thursday that led management to raise its fiscal 2007 forecast. After digging into …
-
Axcan Ulcer Drug Approved
The Food and Drug Administration on Friday approved Axcan's AXCA ulcer treatment formerly known as Helizide. This product kills the Helicobacter pylori bacteria that accounts for most gastric …
-
Axcan Abandons ITAX
Axcan Pharma AXCA announced Wednesday that ITAX failed to meet the necessary endpoints in the second arm of its Phase III trial. As a result, the …
-
Axcan under Review
Axcan Pharma AXCA announced Wednesday that the international arm of its Phase III ITAX trial failed, and we are placing our fair value estimate …
-
Axcan Excels in 1Q
Axcan AXCA reported first-quarter results Thursday that exceeded our expectations. When we adjust for cash flow generated in the quarter …
-
High-Quality Foreign Stocks on Sale
… products and services catering to almost all forms of media, ranging from movie houses to video-game designers." Axcan Pharma AXCA Business Risk: Average Moat: Narrow Domicile: Canada From the Analyst Report : "Axcan has built a highly profitable …